ENBIO Co., Ltd. (KOSDAQ:352940)
2,230.00
-90.00 (-3.88%)
At close: May 20, 2026
ENBIO Market Cap
ENBIO has a market cap or net worth of 24.24 billion as of May 20, 2026. Its market cap has decreased by -8.98% in one year.
Market Cap
24.24B
Enterprise Value
33.31B
Revenue
33.95B
Ranking
n/a
PE Ratio
24.06
Stock Price
2,230.00
Market Cap Chart
Since December 11, 2020, ENBIO's market cap has decreased from 123.03B to 24.24B, a decrease of -80.30%. That is a compound annual growth rate of -25.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 25.21B | 1.98% |
| Dec 30, 2025 | 24.72B | 12.62% |
| Dec 30, 2024 | 21.95B | -42.37% |
| Dec 28, 2023 | 38.09B | -17.82% |
| Dec 29, 2022 | 46.35B | -46.35% |
| Dec 30, 2021 | 86.40B | -45.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alticast | 24.90B |
| Studio Samick | 24.89B |
| PungKang. | 24.64B |
| Daesung Microbiological Labs. | 24.62B |
| Dream Insight | 24.50B |
| Digital Graphics Incorporation | 24.47B |
| Saedong | 24.42B |
| CAS Corporation | 24.40B |